Scout | Protective Strategies to Reduce Amyloid Related Imaging Abnormalities (ARIA) After Anti-Amyloid Beta Immunotherapy (R01

This opportunity is no longer accepting applications.

grant

Protective Strategies to Reduce Amyloid Related Imaging Abnormalities (ARIA) After Anti-Amyloid Beta Immunotherapy (R01 - Clinical Trial Not Allowed)

This grant aims to support research on understanding how brain blood vessels respond to treatments aimed at reducing beta-amyloid, a substance linked to Alzheimer's disease. The focus is on uncovering the cellular and molecular processes involved, especially those that may lead to imaging abnormalities. The ultimate goal is to identify ways to protect the blood-brain barrier and brain blood ve…

Source

Agency: National Institutes of Health

Program: SBIR

Award

Award Ceiling: $500,000

Funding Amount: $500,000

Dates

Opportunity Released: April 10, 2024

Open for Submission: April 10, 2024

Submission Deadline: November 5, 2024

Application Window Closes: November 5, 2024

Keywords

Amyloid

Immunotherapy

Blood Brain Barrier

Brain Blood Vessels

ARIA

Molecular Mechanisms

Anti-beta-amyloid

Therapeutic Interventions

Cellular Mechanisms

Imaging Abnormalities

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers